Department of Paediatrics, University of Tartu, Tartu, Estonia.
Acta Paediatr. 2010 Aug;99(8):1168-74. doi: 10.1111/j.1651-2227.2010.01784.x. Epub 2010 Mar 2.
To determine whether factor V Leiden (FVL) and prothrombin (PT) 20210G>A mutation are associated with paediatric ischaemic stroke.
The study consisted of two parts. Case-control study included neuroradiologically confirmed paediatric ischaemic stroke patients from two tertiary children's hospitals in Estonia. For control group, DNA was obtained from 400 anonymous screening test cards of newborns born consecutively in all delivery departments of Estonia in January 2005. Meta-analyses was performed to assess the association between paediatric sinovenous thrombosis and FVL and PT 20210G>A.
A total of 75 children (45 boys, 30 girls) were included into the case-control study: 19 with childhood arterial ischaemic stroke, 49 with perinatal arterial ischaemic stroke and seven with cerebral venous thrombosis. Both FVL and PT 20210G>A occurred significantly more frequently among patients with sinovenous thrombosis compared with controls (OR = 12.9; 95% CI: 2.3-73.0 and OR = 11.9; 95% CI: 2.1-67.2, respectively). The difference was not significant between childhood/perinatal arterial ischaemic stroke and controls. Meta-analyses (including our study) revealed that both FVL and PT 20210G>A are associated with paediatric sinovenous thrombosis (OR = 3.1; 95% CI: 1.8-5.5 and OR = 3.1; 95% CI: 1.4-6.8, respectively).
FVL and PT 20210G>A are associated with paediatric sinovenous thrombosis.
确定因子 V 莱顿(FVL)和凝血酶原(PT)20210G>A 突变是否与儿科缺血性脑卒中有关。
本研究包括两部分。病例对照研究包括来自爱沙尼亚两家三级儿童医院经神经放射学证实的儿科缺血性脑卒中患者。对照组的 DNA 来自 2005 年 1 月爱沙尼亚所有分娩部门连续出生的 400 张匿名筛查测试卡。荟萃分析用于评估儿科窦静脉血栓形成与 FVL 和 PT 20210G>A 之间的关系。
共纳入 75 名儿童(45 名男孩,30 名女孩)进行病例对照研究:19 名患有儿童动脉缺血性脑卒中,49 名患有围产期动脉缺血性脑卒中,7 名患有脑静脉血栓形成。与对照组相比,FVL 和 PT 20210G>A 在窦静脉血栓形成患者中发生的频率明显更高(OR=12.9;95%CI:2.3-73.0 和 OR=11.9;95%CI:2.1-67.2)。FVL 和 PT 20210G>A 与儿童/围产期动脉缺血性脑卒中与对照组之间的差异无统计学意义。荟萃分析(包括本研究)表明,FVL 和 PT 20210G>A 均与儿科窦静脉血栓形成有关(OR=3.1;95%CI:1.8-5.5 和 OR=3.1;95%CI:1.4-6.8)。
FVL 和 PT 20210G>A 与儿科窦静脉血栓形成有关。